Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
GLP-1: full-pipeline trial registry
8 of 8 indexed GLP-1 trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 8 currently recruiting · #2,176 of 28,707 conditions by registered trial count
GLP-1: 8 US clinical trials tracked, 8 recruiting.
GLP-1 is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is AgelessRx, running 1 of these trials.
Enrollment posture brief
Registry condition glp-1
OPEN 8 | RECR 100% | LATE 2 | EARLY 2 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
GLP-1 lists 8 open slots (100% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for GLP-1 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
GLP-1 is recruiting above its size-band peers.
8 of 8 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of GLP-1 trials is spread across many organizations.
AgelessRx accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical GLP-1 enrolment sits around 120 participants.
Median target enrolment is 120 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
GLP-1 research is mostly interventional.
6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
AgelessRx
NCT07092618
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
The Cleveland Clinic
NCT07127354
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
Athletic Greens International
NCT07437911
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
University of Virginia
NCT06903923
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Mayo Clinic
NCT07213466
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
University of Kansas Medical Center
NCT07422987
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
Dr. Christopher McGowan
NCT06734312
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
The University of Texas Health Science Center at San Antonio
NCT06811324
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on GLP-1 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on GLP-1 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this GLP-1 page
8 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 GLP-1 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AgelessRx sponsors the most GLP-1 trials on record, review their full trial history before evaluating a specific study. See AgelessRx's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This GLP-1 condition card totals 8 registered trials; most-linked intervention naltrexone and bupropion (combination); top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.